hesperidin has been researched along with thromboxane b2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labrid, C | 1 |
| Bodinier, MC; Jean, T | 1 |
| Hase, T; Jokura, H; Shimotoyodome, A; Suzuki, A; Yamamoto, M | 1 |
3 other study(ies) available for hesperidin and thromboxane b2
| Article | Year |
|---|---|
Pharmacologic properties of Daflon 500 mg.
Topics: Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Dinoprostone; Diosmin; Dogs; Drug Combinations; Edema; Flavonoids; Hesperidin; Inflammation; Kidney Glomerulus; Lymph; Muscles; Rats; Thoracic Duct; Thromboxane B2 | 1994 |
Mediators involved in inflammation: effects of Daflon 500 mg on their release.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diosmin; Drug Combinations; Flavonoids; Free Radicals; Granuloma; Hesperidin; Humans; Inflammation; Kidney Glomerulus; Macrophages; Mice; Neutrophils; Permeability; Prostaglandins; Rats; Thromboxane B2 | 1994 |
Effects of continuous ingestion of hesperidin and glucosyl hesperidin on vascular gene expression in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Dietary Supplements; Endothelium, Vascular; Enzyme Repression; Glucosides; Hesperidin; Hypertension; In Vitro Techniques; Male; NADPH Oxidases; Protein Subunits; Random Allocation; Rats; Rats, Inbred SHR; Solubility; Thromboxane B2; Thromboxane-A Synthase; Vascular Resistance | 2013 |